1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Vanda Pharmaceuticals Inc (VNDA)
  7. Quote


Vanda Pharmaceuticals Stock Price

-0.035 (-0.19%)
Upgrade to Real-Time
Regular Market
Volume 20,746
Bid Price 18.24
Ask Price 18.27
News -
Day High 18.48


52 Week Range


Day Low 18.24
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.035 -0.19% 18.265 10:16:30
Open Price Low Price High Price Close Price Prev Close
18.37 18.24 18.48 18.30
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
446 20,746 $ 18.36 $ 380,853 - 10.07 - 21.8627
Last Trade Time Type Quantity Stock Price Currency
10:16:30 1 $ 18.24 USD


Draw Mode:

Vanda Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.02B 55.64M 44.56M $ 248.17M $ 33.68M 0.42 32.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -52.68k 4.80%

more financials information »

Vanda Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VNDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.2918.7517.48518.01398,907-0.025-0.14%
1 Month17.4018.8216.5117.94399,9470.8654.97%
3 Months16.1818.8215.134717.05361,4542.0912.89%
6 Months17.1021.862715.134718.15412,3051.176.81%
1 Year10.1921.862710.0716.56459,2548.0879.24%
3 Years20.0333.447.1215.76595,617-1.77-8.81%
5 Years15.8533.447.1216.22592,2082.4215.24%

Vanda Pharmaceuticals Description

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.

Your Recent History
Vanda Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.